Dabernat H, Delmas C, Lareng M B
Pathol Biol (Paris). 1985 May;33(5):385-8.
The in vitro activities of the new quinolone derivatives ofloxacin, ciprofloxacin, norfloxacin, and pefloxacin against strains of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis were compared to that of nalidixic acid. Determination of minimal inhibitory concentrations (MICs) was done by agar dilution tests. The new drugs were more active than nalidixic acid. N. meningitidis and H. influenzae (regardless of beta-lactamase production) were highly susceptible. All H. influenzae strains were inhibited by less than or equal to 0.12 mg/l; mode MICs were 0.03 mg/l for norfloxacin and pefloxacin, and 0.50 mg/l for nalidixic acid. All N. meningitidis strains were inhibited by 0.06 mg/l and mode MICs of the new drugs were less than or equal to 0.03 mg/l. Mode MICs for S. pneumoniae were 4 mg/l for norfloxacin and pefloxacin (range 1-16 and 2-8 mg/l respectively) and 1 mg/l for ofloxacin (range 1-4 mg/l). Ofloxacin exhibited a bactericidal activity on H. influenzae (range MBC 0.06-0.50 mg/l; mode MBC: 0.06 mg/l).
将氧氟沙星、环丙沙星、诺氟沙星和培氟沙星等新型喹诺酮衍生物对流感嗜血杆菌、肺炎链球菌和脑膜炎奈瑟菌菌株的体外活性与萘啶酸进行了比较。通过琼脂稀释试验测定最低抑菌浓度(MIC)。这些新药比萘啶酸更具活性。脑膜炎奈瑟菌和流感嗜血杆菌(无论是否产β-内酰胺酶)都高度敏感。所有流感嗜血杆菌菌株均被抑制在小于或等于0.12mg/L;诺氟沙星和培氟沙星的MIC中位数为0.03mg/L,萘啶酸为0.50mg/L。所有脑膜炎奈瑟菌菌株均被0.06mg/L抑制,新药的MIC中位数小于或等于0.03mg/L。诺氟沙星和培氟沙星对肺炎链球菌的MIC中位数为4mg/L(范围分别为1-16mg/L和2-8mg/L),氧氟沙星为1mg/L(范围为1-4mg/L)。氧氟沙星对流感嗜血杆菌具有杀菌活性(MBC范围为0.06-0.50mg/L;MBC中位数:0.06mg/L)。